ArticleBiomedicines2025

The Role of Glycemic Control in Inflammation Markers and Clinical Outcomes in Type 2 Diabetes Patients with Severe COVID-19.

Lavinia Craciun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.